Risk Know-How is a new online platform launched at the AAAS meeting on 16 February. It is for communities that face threats such as disease outbreaks, extreme weather and risks linked to artificial intelligence. The platform is built around the Risk Know-How Framework, a short summary of key ideas about risk information.
Groups can ask the Risk Know-How team for help to connect with others, get funding or take part in training. The main rule is that participating groups must share their experience on the platform. The site also publishes case studies, for example a communication campaign that used local bakeries and sign language interpreters to reach different people.
Difficult words
- platform — website or online place for people to meet
- outbreak — a sudden start of disease in a placeoutbreaks
- extreme weather — very strong storms, heat or cold events
- framework — a short plan or set of main ideas
- funding — money to pay for a project or activity
- case study — a story that shows how a problem was solvedcase studies
- interpreter — a person who changes speech into sign languageinterpreters
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would your community share experience on a public platform? Why or why not?
- Have you seen a communication campaign that used local shops or interpreters? How did it help?
- Which risks (disease, extreme weather, or AI) worry people where you live?
Related articles
Internet use may reduce loneliness for older unpaid caregivers
A US study found that older unpaid caregivers who use the internet more often tend to feel less lonely. Researchers analysed 2019–2020 California survey data from 3,957 caregivers aged 65 and older; about 12% had health problems.
AI tool helps local autism diagnosis in Missouri
Researchers at the University of Missouri tested the FDA-approved CanvasDx, an AI device, to help primary care evaluate autism where specialty centres are far away. In a study it gave determinate results for 52% of 80 children and matched clinicians' diagnoses.